V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20210493 | 20078332 | null | 56 | Palliative (P) | 2018-12-27 | 2018-12-27 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101759679 |
| 20210497 | 20078333 | 1.78 | 75 | Curative (C) | 2018-10-18 | 2018-10-19 | CAPECITABINE + CARBOPLATIN | N | N | CAPECITABINE + CARBOPLATIN | 100887776 |
| 20210502 | 20078334 | 1.78 | 65.5 | Palliative (P) | 2019-11-10 | 2019-12-04 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101268671 |
| 20210503 | 20078335 | 0.97 | 98.3 | Curative (C) | null | 2019-03-19 | Capecitabine (21days) + Carboplatin | 02 | Y | CAPECITABINE + CARBOPLATIN | 101725928 |
| 20210504 | 20078336 | 1.73 | 82.2 | Palliative (P) | 2019-06-30 | 2019-07-08 | Capecitabine (21days) + Carboplatin | N | N | CAPECITABINE + CARBOPLATIN | 100560326 |
| 20210511 | 20078337 | 0 | 0 | Neo-adjuvant (N) | 2016-06-18 | 2016-07-07 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100673718 |
| 20210516 | 20078338 | 0 | 0 | Palliative (P) | null | 2019-08-15 | Doxorubicin chemoembolisation | null | N | DOXORUBICIN EMBOLISATION | 101325536 |
| 20210525 | 20078339 | 0 | 43 | Palliative (P) | 2019-10-12 | 2019-10-13 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100993005 |
| 20210526 | 20078340 | null | null | null | 2019-01-22 | 2019-02-18 | CAPECITABINE + CARBOPLATIN | 02 | null | DOXORUBICIN EMBOLISATION | 100289059 |
| 20210528 | 20078341 | 0 | 0 | Neo-adjuvant (N) | 2019-09-07 | 2019-09-10 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101592364 |
| 20210529 | 20078342 | 0 | 0 | null | 2019-02-18 | 2019-03-02 | Capecitabine (21days) + Carboplatin | 02 | null | DOXORUBICIN EMBOLISATION | 101223355 |
| 20210544 | 20078343 | null | null | null | 2018-01-27 | 2018-02-23 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100236623 |
| 20210546 | 20078344 | 1.71 | 77.2 | null | 2019-08-13 | 2019-08-28 | Cisplatin + Fluorouracil + RT 5day | 02 | null | CISPLATIN + FLUOROURACIL | 100318993 |
| 20210551 | 20078345 | 1.83 | 54.2 | Palliative (P) | 2017-02-02 | 2017-02-03 | CISPLATIN + FLUOROURACIL | N | N | CISPLATIN + FLUOROURACIL | 100584240 |
| 20210562 | 20078346 | 1.65 | 79.6 | Curative (C) | 2019-02-28 | 2019-03-13 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101311705 |
| 20210564 | 20078347 | 1.65 | 84 | Curative (C) | 2019-08-19 | 2019-09-01 | CISPLATIN + FLUOROURACIL + RT | 02 | N | CISPLATIN + FLUOROURACIL | 100097038 |
| 20210580 | 20078348 | 1.75 | 65.6 | null | 2019-02-06 | 2019-02-18 | CAPECITABINE + CARBOPLATIN | 02 | null | CISPLATIN + FLUOROURACIL | 101011396 |
| 20210581 | 20078349 | 1.9 | 69.4 | Palliative (P) | null | 2016-12-07 | Capecitabine + Carboplatin + RT | 02 | N | CAPECITABINE + CARBOPLATIN | 101141439 |
| 20210582 | 20078350 | 1.74 | 76.6 | Palliative (P) | 2019-10-19 | 2019-10-21 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100371402 |
| 20210584 | 20078351 | 0 | 0 | Palliative (P) | 2016-05-23 | 2016-05-23 | Capecitabine (21days) + Carboplatin | 2 | N | DOXORUBICIN EMBOLISATION | 101696143 |
| 20210594 | 20078352 | 1.86 | 95.8 | null | 2018-06-12 | 2018-06-22 | Cisplatin +Fluorouracil (3 wk) | null | null | CISPLATIN + FLUOROURACIL | 100435127 |
| 20210602 | 20078353 | null | 66.1 | Palliative (P) | 2016-03-03 | 2016-03-04 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100935576 |
| 20210603 | 20078354 | 1.66 | 71.2 | Neo-adjuvant (N) | 2017-11-28 | 2017-11-28 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101314909 |
| 20210606 | 20078355 | 1.82 | 78 | Neo-adjuvant (N) | 2019-10-27 | 2019-11-09 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100607296 |
| 20210615 | 20078356 | 1.78 | 66.1 | Curative (C) | 2016-07-27 | 2016-08-11 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100664138 |
| 20210617 | 20078357 | 1.75 | 94.4 | Palliative (P) | 2017-06-17 | 2017-07-01 | Doxorubicin chemoembolisation | null | N | DOXORUBICIN EMBOLISATION | 101627652 |
| 20210618 | 20078358 | 1.54 | 75.9 | Neo-adjuvant (N) | null | 2016-09-16 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101660319 |
| 20210621 | 20078359 | null | 68 | Neo-adjuvant (N) | 2020-08-31 | 2020-09-22 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100424574 |
| 20210623 | 20078360 | 0 | 0 | Neo-adjuvant (N) | 2020-11-04 | 2020-12-02 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100239071 |
| 20210626 | 20078361 | 1.59 | 55.5 | Palliative (P) | 2017-05-10 | 2017-06-06 | Doxorubicin chemoembolisation | null | N | DOXORUBICIN EMBOLISATION | 101645890 |
| 20210627 | 20078362 | 0 | 0 | null | 2019-01-27 | 2019-02-11 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 101064799 |
| 20210631 | 20078363 | 0 | 0 | Neo-adjuvant (N) | 2019-12-08 | 2019-12-20 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 101087621 |
| 20210633 | 20078364 | 0 | 57.5 | Neo-adjuvant (N) | 2021-12-17 | 2022-01-01 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101323083 |
| 20210637 | 20078365 | 1.67 | 68.5 | Neo-adjuvant (N) | 2017-08-20 | 2017-08-22 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100401046 |
| 20210640 | 20078366 | 1.57 | 67 | Palliative (P) | 2016-12-15 | 2016-12-29 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101303690 |
| 20210646 | 20078367 | 1.57 | 62.7 | Neo-adjuvant (N) | 2017-09-05 | 2017-09-05 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 100583872 |
| 20210650 | 20078368 | null | 67.6 | Palliative (P) | 2017-03-18 | 2017-04-14 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101557938 |
| 20210651 | 20078369 | 0 | 0 | Curative (C) | 2021-01-03 | 2021-02-08 | Doxorubicin chemoembolisation | 99 | Y | DOXORUBICIN EMBOLISATION | 100340470 |
| 20210658 | 20078370 | 0 | 0 | Curative (C) | 2018-08-19 | 2018-10-01 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100497494 |
| 20210665 | 20078371 | 1.64 | 75.8 | Palliative (P) | 2020-02-19 | 2020-02-26 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101832039 |
| 20210667 | 20078372 | 1.61 | 69.7 | 03 | 2018-04-01 | 2018-04-22 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CISPLATIN + FLUOROURACIL | 100790066 |
| 20210673 | 20078373 | 0 | 0 | Palliative (P) | 2019-01-08 | 2019-02-04 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100894452 |
| 20210674 | 20078374 | 0 | 0 | Curative (C) | 2019-03-01 | 2019-03-22 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101139131 |
| 20210683 | 20078375 | 0 | 0 | Palliative (P) | 2018-05-21 | 2018-06-14 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100667572 |
| 20210685 | 20078376 | 1.72 | 68.6 | Neo-adjuvant (N) | 2020-03-22 | 2020-03-22 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 101644254 |
| 20210686 | 20078377 | 1.76 | 79.75 | null | 2019-03-23 | 2019-03-23 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100199083 |
| 20210694 | 20078378 | 1.64 | 66.2 | Palliative (P) | 2017-02-15 | 2017-03-03 | Capecitabine (21days) + Carboplatin | N | N | CAPECITABINE + CARBOPLATIN | 100991053 |
| 20210705 | 20078379 | 0.97 | 65.75 | Neo-adjuvant (N) | 2019-10-19 | 2019-10-31 | Capecitabine (21days) + Carboplatin | N | N | CAPECITABINE + CARBOPLATIN | 100306599 |
| 20210707 | 20078380 | 1.76 | 87.6 | Curative (C) | 2016-05-05 | 2016-05-05 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100535174 |
| 20210709 | 20078381 | 1.54 | 87.25 | Palliative (P) | 2017-02-09 | 2017-02-15 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100267212 |